$19.1M Funding Achieved To Date For Product Development

Funding from these major sources; Management and Advisory Teams, Angel Investors, Kyowa Hakko Kirin, Oklahoma Medical Research Foundation, Texas Emerging Technology Fund, National Cancer Institute, National Institutes of Health, Oklahoma Center for the Advancement of Science & Technology,  Juvenile Diabetes Research Foundation, and MD Anderson Cancer Center.